Mechanistic insights and clinical benefits of omega-3 fatty acids in cardiovascular, inflammatory, and neurological health
Open Access
- 26 June 2025
- journal article
- Published by Office of Academic Resources, Chulalongkorn University - DIGITAL COMMONS JOURNALS in The Thai Journal of Pharmaceutical Sciences
- Vol. 49 (2) , 1
Abstract
Background: Omega-3 polyunsaturated fatty acids (ω-3 PUFAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are attributed with the capacity to prevent cardiovascular diseases (CVD), chronic inflammation, and neurodegenerative diseases. Their bioactive contribution consists on interfering with lipid metabolism, decreasing inflammation, and increasing neuroprotection. Still, the findings imply that there is a considerable need for greater clarification of their mechanisms and their application to clinical care. Objectives: This narrative review is intended to discuss the potential target(s) of action, uses, and efficacy of ω-3 PUFAs in the context of CVD, inflammation, and neurodegenerative diseases. Materials and Methods: This narrative review was conducted through a comprehensive literature search using databases such as PubMed, Scopus, and Google Scholar. Studies published from the last 10 years were included, focusing on omega-3 fatty acids’ effects on cardiovascular, inflammatory, and neurological health. Both experimental and clinical studies were considered. Key search terms included “omega-3 fatty acids,” “eicosapentaenoic acid (EPA),” “docosahexaenoic acid (DHA),” “cardiovascular health,” “inflammation,” “neurological diseases,” and “safety profile.” The inclusion criteria were peerreviewed articles in English that provided relevant mechanistic insights and clinical outcomes. Results: EPA and DHA have been shown to reduce triglyceride levels, improve endothelial function, stabilize atherosclerotic plaques, and exhibit anti-arrhythmic properties. Inflammation is modulated through inhibition of nuclear factor kappa B and the production of specialized pro-resolving mediators such as resolvins and protectins. DHA also provides neuroprotection by enhancing membrane fluidity, reducing oxidative stress, and inhibiting apoptosis through the production of neuroprotection D1. Clinical trials such as the GISSI-prevenzione and Japan EPA lipid intervention study studies confirm the cardioprotective benefits of ω-3 supplementation. Conclusion: The evidence strongly supports the therapeutic potential of ω-3 PUFAs in CVDs, chronic inflammations, and neurodegenerative diseases. Given the various ways that these nutrients are now known to exert their effects from lipid modulation to neuroprotection, the latter would be useful in the prevention and management of diseases and promotion of health.Keywords
This publication has 58 references indexed in Scilit:
- The role of polyunsaturated fatty acids in neuronal signaling in depression and cognitive processesArchives of Biochemistry and Biophysics, 2023
- Dietary Polyunsaturated Fatty Acids (PUFAs): Uses and Potential Health BenefitsCurrent Nutrition Reports, 2021
- Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple SclerosisClinical Reviews in Allergy & Immunology, 2021
- The Role of Chronic Inflammation in Various Diseases and Anti‐inflammatory Therapies Containing Natural ProductsChemMedChem, 2021
- EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, crossover studyAtherosclerosis, 2021
- Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapyBiomedicine & Pharmacotherapy, 2017
- The expansive role of oxylipins on platelet biologyJournal of Molecular Medicine, 2017
- Safety Considerations with Omega-3 Fatty Acid TherapyThe American Journal of Cardiology, 2007
- Secondary Prevention of Coronary Artery Disease with Omega-3 Fatty AcidsThe American Journal of Cardiology, 2006
- The Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto miocardio (GISSI)-Prevenzione trial on fish oil and vitamin E supplementation in myocardial infarction survivorsCurrent Cardiology Reports, 2000